# OnCo record fight-302 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/fight-302/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "fight-302", "NCT03656536" ;
  schema:name "FIGHT-302"@en ;
  schema:description "FIGHT-302 set out to test whether the FGFR2 inhibitor pemigatinib should be used before chemotherapy in bile duct cancers driven by an FGFR2 fusion; the trial was stopped before it could answer the question."@en ;
  schema:url <https://onco.cc/trials/fight-302/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03656536> ;
  onco:status "withdrawn" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:drugs <https://onco.cc/drugs/pemigatinib/>, <https://onco.cc/drugs/gemcitabine-cisplatin/> ;
  onco:companies <https://onco.cc/companies/incyte/> ;
  onco:people <https://onco.cc/people/tanios-bekaii-saab/> .